Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

C11-Sodium Acetate PET/CT Imaging for Metastatic Disease in Intermediate-to-high Risk Prostate Adenocarcinoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2014 by Arizona Molecular Imaging Center
Sponsor:
Information provided by (Responsible Party):
Fabio Almeida MD, Arizona Molecular Imaging Center
ClinicalTrials.gov Identifier:
NCT01530269
First received: February 4, 2012
Last updated: June 4, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2017
  Estimated Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)